Atossa Therapeutics, Inc. (ATOS) NASDAQ
5.01
-0.04(-0.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.01
-0.04(-0.79%)
Currency In USD
| Market Cap | 118.81M |
| Enterprise Value | 47.73M |
| P/E Ratio | -1.43 |
| PEG Ratio | 0.32 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.27 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.52 |
| Return On Equity | -0.49 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -17,000 |
| EBITDA | -27.6M |
| Net Income | -25.5M |
| Diluted EPS | -3 |
| Total Cash | 51.85M |
| Total Cash/Share | 6.02 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.77 |
| Book Value Per Share | 5.78 |
| 52-Week Change | -53.61 |
| 52-Week High | 19.35 |
| 52-Week Low | 3.76 |
| Moving Average 50 Days | 6.75 |
| Moving Average 200 Days | 11.11 |
| Average Volume | 145,063 |
| Shares Outstanding | 8.61M |
| % Held by Institutions | 16.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 02, 2026 |